Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Chronic cerebrospinal venous insufficiency--pathophysiology and treament].
Prolongation of survival of rat cardiac allografts by T cell vaccination.
Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases.
Peripheral neuropathy associated with mitochondrial disease in children.
Harnessing monocyte-derived macrophages to control central nervous system pathologies: No longer 'if' but 'how'
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.
The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology.
Multiple Sclerosis in Children.
Immunomodulators for multiple sclerosis may ameliorate spinal bone loss.
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
[Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue.]
[Differential diagnosis of late-stage neuroborreliosis with affection of the central nervous system.]
Speedy eye movements in multiple sclerosis: Association with performance on visual and nonvisual cognitive tests.
Age-Dependent Seroprevalence of JCV Antibody in Children.
The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?
Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.
Correction: quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.
Complex molecular and functional outcomes of single versus sequential cytokine stimulation of rat microglia.
Development of nucleic acid drugs for neurological disorders.
Cost-sharing and initiation of disease-modifying therapy for multiple sclerosis.
Brain Region-specific Alterations in the Gene Expression of Cytokines, Immune Cell Markers and Cholinergic System Components During Peripheral Endotoxin-induced Inflammation.
Redox regulation of NF-κB p50 and M1 polarization in microglia.
Peripheral blood T cell dynamics predict relapse in multiple sclerosis patients on fingolimod.
Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients.
Smoking and Risk of Multiple Sclerosis: Evidence of Modification by NAT1 Variants.
Pages
« first
‹ previous
…
205
206
207
208
209
210
211
212
213
…
next ›
last »